...
首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Prevalence of the A1555G (12S rRNA) and tRNA Ser(UCN) mitochondrial mutations in hearing-impaired Brazilian patients
【24h】

Prevalence of the A1555G (12S rRNA) and tRNA Ser(UCN) mitochondrial mutations in hearing-impaired Brazilian patients

机译:听力障碍巴西患者中A1555G(12S rRNA)和tRNA Ser(UCN)线粒体突变的患病率

获取原文

摘要

Mitochondrial mutations are responsible for at least 1% of the cases of hereditary deafness, but the contribution of each mutation has not yet been defined in African-derived or native American genetic backgrounds. A total of 203 unselected hearing-impaired patients were screened for the presence of the mitochondrial mutation A1555G in the 12S rRNA gene and mutations in the tRNA Ser(UCN) gene in order to assess their frequency in the ethnically admixed Brazilian population. We found four individuals with A1555G mutation (2%), which is a frequency similar to those reported for European-derived populations in unselected samples. On the other hand, complete sequencing of the tRNA Ser(UCN) did not reveal reported pathogenic substitutions, namely A7445G, 7472insC, T7510C, or T7511C. Instead, other rare substitutions were found such as T1291C, A7569G, and G7444A. To evaluate the significance of these findings, 110 "European-Brazilians" and 190 "African-Brazilians" unrelated hearing controls were screened. The T1291C, A7569G and G7444A substitutions were each found in about 1% (2/190) of individuals of African ancestry, suggesting that they are probably polymorphic. Our results indicate that screening for the A1555G mutation is recommended among all Brazilian deaf patients, while testing for mutations in the tRNA Ser(UCN) gene should be considered only when other frequent deafness-causing mutations have been excluded or in the presence of a maternal transmission pattern.
机译:线粒体突变至少占遗传性耳聋病例的1%,但每种突变的贡献在非洲或美国本土遗传背景中尚未确定。总共筛选了203名未选出的听力障碍患者,以检测其12S rRNA基因中是否存在线粒体突变A1555G和tRNA Ser(UCN)基因中的突变,以评估其在巴西种族混合人群中的频率。我们发现了四个具有A1555G突变(2%)的个体,该频率与未选择样品中欧洲来源人群报道的频率相似。另一方面,tRNA Ser(UCN)的完整测序未揭示报告的病原体取代,即A7445G,7472insC,T7510C或T7511C。相反,发现了其他罕见的替代物,例如T1291C,A7569G和G7444A。为了评估这些发现的重要性,筛选了110个“欧洲-巴西”和190个“非洲-巴西”无关的听力对照。 T1291C,A7569G和G7444A替代分别在大约1%(2/190)的非洲血统个体中发现,表明它们可能是多态的。我们的结果表明,建议在所有巴西耳聋患者中筛查A1555G突变,而仅当排除了其他常见的耳聋致突变或有孕妇时,才应考虑测试tRNA Ser(UCN)基因的突变传输模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号